The present invention relates to a .beta.3 adrenergic receptor agonist of formula I: ##STR00001## or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.

 
Web www.patentalert.com

< Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof

< Phosphodiesterase 4 inhibitors

> Substituted piperidine compounds and methods of their use

> Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
~ 00280